Related Experiment Videos
Streptokinase therapy in a five-year-old child with prosthetic mitral valve thrombosis
1Department of Cardiology, All India Institute of Medical Sciences, New Delhi.
International Journal of Cardiology
|July 15, 1993
Insights
Intravenous streptokinase therapy is a rare but safe and effective treatment for pediatric prosthetic valve thrombosis. This approach should be considered a primary therapy option for children, mirroring adult treatment protocols.
Area of Science:
- Cardiology
- Pediatric Medicine
- Pharmacology
Background:
- Prosthetic valve thrombosis (PVT) is a serious complication following cardiac valve replacement surgery.
- PVT in pediatric patients is exceptionally rare, presenting unique clinical challenges.
- Limited data exists on the efficacy and safety of thrombolytic therapy in children with PVT.
Abstract:
Intravenous streptokinase therapy for prosthetic valve thrombosis in a 5-year-old child is reported for its rarity. The therapy is safe and effective and as in adults, should be considered the first line of treatment for prosthetic valve thrombosis in children.